Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EXE | EOG |
|---|---|---|
| Price | $85.73 | $141.01 |
| Change today | ▲ 1.95% | ▲ 2.36% |
| Market cap | $19.85B | $73.96B |
| Return, 3 months | -3.7% | +10.5% |
| Return, year to date | -21.0% | +37.6% |
| Return, 1 year | -19.7% | +31.1% |
| P/E (TTM) | 7.4 | 11.0 |
| P/B | 1.0 | 2.3 |
| P/E percentile vs own 5y | 71st | 65th |
| Dividend yield | 3.72% | 2.86% |
| Revenue growth (YoY, latest qtr) | -19.7% | +58.6% |
| Net profit growth (YoY) | -46.1% | +102.5% |
| Gross margin | 54.2% | 65.4% |
| Operating margin | 29.3% | 35.4% |
| Net margin | 20.4% | 25.8% |
| Return on equity | 14.9% | 22.5% |
| Analyst target vs. price | +46.3% | +14.7% |
| Analyst buy share | 83% | 47% |
| RSI (14) | 27 | 40 |
| 30-day volatility | 24.6% | 27.5% |
| Max drawdown, 1 year | -30.4% | -13.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
